Insulet Corporation (PODD) Stock Price

PODDStockS&P 500

$141.10−55.39%52W

Market Cap$9.79B

P/E39.60x

PEG Ratio1.11

Div yield—

Beta1.08

PODD Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-39.88%

Price vs S&P 500 (4W)1.73%

PEG Ratio1.11

VGM Score58.13

P/E Ratio (Annual)39.60x

P/CF (Annual)17.19x

Book Value / Share (Quarterly)$21.53

P/TBV (Annual)14.30x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)27.54%

Cash Flow / Share (Quarterly)$4.97

Price vs S&P 500 (YTD)-62.29%

Gross Margin (TTM)71.08%

Net Profit Margin (TTM)12.29%

EPS (TTM)$5.35

10-Day Avg Trading Volume1.54M

EPS Excl Extra (TTM)$5.35

Revenue Growth (5Y)24.53%

EPS (Annual)$3.44

ROI (Annual)10.03%

Gross Margin (Annual)71.63%

Net Profit Margin (5Y Avg)8.67%

Cash / Share (Quarterly)$10.17

P/E Basic Excl Extra (TTM)26.07x

Revenue Growth QoQ (YoY)23.51%

EPS Growth (5Y)101.61%

P/E Normalized (Annual)39.60x

ROA (Last FY)7.75%

Revenue Growth TTM (YoY)29.41%

EBITD / Share (TTM)$8.76

ROE (5Y Avg)16.60%

Operating Margin (TTM)16.89%

Cash Flow / Share (Annual)$4.97

P/B Ratio6.46x

P/B Ratio (Quarterly)13.20x

Net Income / Employee (Annual)$45,800

EV / Revenue (TTM)3.70x

Net Interest Coverage (TTM)33.64x

ROA (TTM)7.49%

EPS Growth QoQ (YoY)329.76%

EV / EBITDA (TTM)22.75x

EPS Incl Extra (Annual)$3.44

Current Ratio (Annual)2.81x

Quick Ratio (Quarterly)1.81x

3-Month Avg Trading Volume1.63M

52-Week Price Return-55.39%

EV / Free Cash Flow (Annual)28.64x

P/E Incl Extra (TTM)26.07x

Revenue / Employee (TTM)$565,500

Tangible BV / Share (Quarterly)$19.86

P/S Ratio (Annual)3.61x

Asset Turnover (Annual)0.85x

52-Week High$354.88

Operating Margin (5Y Avg)10.26%

EPS Excl Extra (Annual)$3.44

CapEx CAGR (5Y)5.67%

Tangible BV CAGR (5Y)19.45%

26-Week Price Return-29.97%

Quick Ratio (Annual)1.81x

13-Week Price Return-13.99%

Total Debt / Equity (Annual)0.63x

Current Ratio (Quarterly)2.81x

Enterprise Value$10.02B

Revenue / Share Growth (5Y)22.38%

Asset Turnover (TTM)0.82x

Book Value / Share Growth (5Y)18.67%

Revenue / Employee (Annual)$501,500

Inventory Turnover (Annual)1.74x

Pretax Margin (Annual)12.54%

Cash / Share (Annual)$10.17

3-Month Return Std Dev51.72%

Gross Margin (5Y Avg)67.99%

Net Income / Employee (TTM)$69,500

EBITDA CAGR (5Y)32.73%

EBITDA Interim CAGR (5Y)156.82%

ROE (Last FY)16.31%

Net Interest Coverage (Annual)14.72x

EPS Basic Excl Extra (Annual)$3.44

P/FCF (TTM)36.84x

Receivables Turnover (TTM)6.14x

EV / Free Cash Flow (TTM)37.72x

Total Debt / Equity (Quarterly)0.63x

EPS Incl Extra (TTM)$5.35

Receivables Turnover (Annual)6.14x

ROI (TTM)9.20%

P/S Ratio (TTM)3.20x

Pretax Margin (5Y Avg)8.46%

Revenue / Share (Annual)$37.67

Tangible BV / Share (Annual)$19.86

Forward P/E19.13x

Price vs S&P 500 (52W)-70.92%

P/E Ratio (TTM)26.07x

EPS Growth TTM (YoY)66.85%

Year-to-Date Return-50.36%

5-Day Price Return0.92%

EPS Normalized (Annual)$3.44

ROA (5Y Avg)6.06%

Net Profit Margin (Annual)9.12%

Month-to-Date Return8.15%

Cash Flow / Share (TTM)$2.67

EBITD / Share (Annual)$6.13

EPS Growth (3Y)273.82%

Operating Margin (Annual)12.92%

LT Debt / Equity (Annual)0.61x

P/CF (TTM)19.14x

ROI (5Y Avg)7.37%

P/E Excl Extra (TTM)26.07x

LT Debt / Equity (Quarterly)0.61x

EPS Basic Excl Extra (TTM)$5.35

P/TBV (Quarterly)14.30x

P/B Ratio (Annual)13.20x

Inventory Turnover (TTM)1.74x

Pretax Margin (TTM)16.20%

Book Value / Share (Annual)$21.53

Price vs S&P 500 (13W)-16.68%

Net Margin Growth (5Y)64.81%

Beta1.08x

P/FCF (Annual)27.98x

Revenue / Share (TTM)$44.00

ROE (TTM)17.37%

52-Week Low$126.40

vGradeC

gGradeA

mGradeC

vgmGradeC

PODD Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	$1.45	$1.66	+14.28%(+$0.21)
Q1 2026	May 6, 2026	$1.19	$1.42	+19.26%(+$0.23)
Q4 2025	Feb 18, 2026	$1.46	$1.55	+5.97%(+$0.09)
Q3 2025	Nov 6, 2025	$1.15	$1.24	+8.07%(+$0.09)
Q2 2025	Aug 7, 2025	$0.92	$1.17	+26.81%(+$0.25)

PODD Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.24

4.20

4.18

3.88

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24
RCELAvita Medical, Inc. Common Stock	D	C	A	5.3x	19.6%	82.1%	-46.6%	$13.04

About Insulet Corporation

Insulet manufactures the Omnipod system, a smartphone-controlled, disposable insulin infusion device that simplifies continuous insulin therapy for diabetic patients. FDA-approved since 2005, the system has been adopted by approximately 500,000 patients worldwide, establishing Insulet as a leader in automated insulin delivery solutions.

PODD Next Earnings Report

Report dateNov 4, 2026

QuarterQ3 2026

Report timeBMO

EPS estimate$1.59

Revenue estimate$832.64M

Also reporting on Nov 4, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

COOThe Cooper Companies, Inc. Common StockOphthalmic Goods
ONTOOnto Innovation Inc.Measuring & Controlling Devices
ALGNAlign Technology IncOrthopedic & Prosthetic Devices
NVMINova Ltd. Ordinary SharesOptical Instruments & Lenses
BIO.BBio-Rad Laboratories, Inc. Class BLab Analytical Instruments
BIOBio-Rad Laboratories, Inc.Class ALab Analytical Instruments
DRSLeonardo DRS, Inc. Common StockDefense Systems & Equipment
TXG10x Genomics, Inc. Class A Common StockLab Analytical Instruments

Same SIC sector, outside this company's own industry.

Analyst Sentiment

3.9

Buy

Consensus rating

52-Week Range

Low$126.40

High$354.88